<p><strong>亨斯迈公司</strong>（NYSE:HUN）的股东无疑会高兴地看到，股价在过去一个月上涨了 27%，尽管它仍在努力弥补最近失去的地盘。然而，并不是所有股东都会感到欢欣鼓舞，因为股价在过去一年中仍然下跌了令人失望的 47%。</p>
<p>尽管股价大幅反弹，但考虑到美国化工行业约一半的公司市销率（或称&#34;P/S&#34;）超过 1.1 倍，您仍然可以将亨斯迈视为一个稳健的投资机会，其市销率为 0.3 倍。不过，仅仅将市销率视为表面值并不明智，因为可能有解释说明其受限的原因。</p>
<p>特朗普承诺要&#34;释放&#34;美国的石油和天然气，这 15 只美国股票的发展有望受益。</p>
<p>查看我们对亨斯迈的最新分析</p>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/asset/chart/165298-ps-multiple-vs-industry-1-dark-2/1764505746406?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/asset/chart/165298-ps-multiple-vs-industry-1-dark-2/1764505746406"/></p>
<p>NYSE:HUN 市销率与行业比较 2025 年 11 月 30 日</p>
<h3>亨斯迈的表现如何</h3>
<p>尽管行业最近经历了收入增长，但亨斯迈的收入却出现了下滑，这并不理想。也许市销率之所以保持低位，是因为投资者认为强劲的收入增长前景并不在眼前。如果是这样，那么现有股东可能会对股价未来的走势感到失望。</p>
<p>想知道分析师如何看待亨斯迈的未来与行业的对比吗？那么我们的 <strong>免费</strong> 报告是一个很好的起点。</p>
<h2>收入预测是否与低市销率相符？</h2>
<p>您唯一会真正感到舒适的情况是，当公司的增长预计将落后于行业时，市销率低至亨斯迈的水平。</p>
<p>首先回顾一下，去年公司的收入增长并不令人兴奋，出现了令人失望的 3.5% 的下降。这意味着在更长的时间内，收入也出现了下滑，过去三年总收入下降了 32%。因此，不幸的是，我们必须承认公司在这段时间内未能有效地增长收入。</p>
<p>展望未来，分析师预计明年将实现 1.1% 的增长。这显然低于更广泛行业的 5.5% 的增长预测。</p>
<p>鉴于此，亨斯迈的市销率低于大多数其他公司是可以理解的。似乎大多数投资者预计未来增长有限，因此只愿意为该股票支付较低的价格。</p>
<h2>亨斯迈的市销率对投资者意味着什么？</h2>
<p>最新的股价飙升并不足以将亨斯迈的市销率拉近行业中位数。虽然市销率不应成为您是否购买股票的决定性因素，但它是收入预期的一个相当有效的晴雨表。</p>
<p>我们已经确定亨斯迈维持其低市销率的原因在于其预测增长低于更广泛行业的预期。股东对公司收入前景的悲观情绪似乎是导致市销率低迷的主要原因。公司需要改变运势，以证明未来市销率的上升是合理的。</p>
<p>我们不想过于泼冷水，但我们确实发现了 <strong>亨斯迈的 2 个警告信号</strong>（其中 1 个让我们感到不安！）您需要注意。</p>
<p>当然，<strong>盈利能力强且有良好盈利增长历史的公司通常是更安全的投资</strong>。因此，您可能希望查看这份 <strong>免费</strong> 的其他公司集合，这些公司具有合理的市盈率并且盈利增长强劲。</p>

亨斯迈

<p>亨斯迈公司的股票最近上涨了 27%，但其市销率仍然较低，仅为 0.3 倍，而行业平均为 1.1 倍。尽管股价上涨，亨斯迈的收入在三年内下降了 32%，预计明年的增长仅为 1.1%，低于行业的 5.5%。由于收入前景疲弱，投资者保持谨慎，这影响了股票的估值</p>

<p><strong>Huntsman Corporation</strong> (NYSE:HUN) shareholders are no doubt pleased to see that the share price has bounced 27% in the last month, although it is still struggling to make up recently lost ground. Not all shareholders will be feeling jubilant, since the share price is still down a very disappointing 47% in the last twelve months.</p>
<div class="lb-trans"><p><strong>亨斯迈公司</strong>（NYSE:HUN）的股东无疑会高兴地看到，股价在过去一个月上涨了 27%，尽管它仍在努力弥补最近失去的地盘。然而，并不是所有股东都会感到欢欣鼓舞，因为股价在过去一年中仍然下跌了令人失望的 47%。</p>
</div><p>In spite of the firm bounce in price, considering around half the companies operating in the United States' Chemicals industry have price-to-sales ratios (or &#34;P/S&#34;) above 1.1x, you may still consider Huntsman as an solid investment opportunity with its 0.3x P/S ratio. Although, it's not wise to just take the P/S at face value as there may be an explanation why it's limited.</p>
<div class="lb-trans"><p>尽管股价大幅反弹，但考虑到美国化工行业约一半的公司市销率（或称&#34;P/S&#34;）超过 1.1 倍，您仍然可以将亨斯迈视为一个稳健的投资机会，其市销率为 0.3 倍。不过，仅仅将市销率视为表面值并不明智，因为可能有解释说明其受限的原因。</p>
</div><p>Trump has pledged to &#34;unleash&#34; American oil and gas and these 15 US stocks have developments that are poised to benefit.</p>
<div class="lb-trans"><p>特朗普承诺要&#34;释放&#34;美国的石油和天然气，这 15 只美国股票的发展有望受益。</p>
</div><p>See our latest analysis for Huntsman</p>
<div class="lb-trans"><p>查看我们对亨斯迈的最新分析</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/asset/chart/165298-ps-multiple-vs-industry-1-dark-2/1764505746406" alt="" original-src="https://images.simplywall.st/asset/chart/165298-ps-multiple-vs-industry-1-dark-2/1764505746406"/></p>
<p>NYSE:HUN Price to Sales Ratio vs Industry November 30th 2025</p>
<div class="lb-trans"><p>NYSE:HUN 市销率与行业比较 2025 年 11 月 30 日</p>
</div><h3>How Huntsman Has Been Performing</h3>
<div class="lb-trans"><h3>亨斯迈的表现如何</h3>
</div><p>While the industry has experienced revenue growth lately, Huntsman's revenue has gone into reverse gear, which is not great. Perhaps the P/S remains low as investors think the prospects of strong revenue growth aren't on the horizon. If this is the case, then existing shareholders will probably struggle to get excited about the future direction of the share price.</p>
<div class="lb-trans"><p>尽管行业最近经历了收入增长，但亨斯迈的收入却出现了下滑，这并不理想。也许市销率之所以保持低位，是因为投资者认为强劲的收入增长前景并不在眼前。如果是这样，那么现有股东可能会对股价未来的走势感到失望。</p>
</div><p>Keen to find out how analysts think Huntsman's future stacks up against the industry? In that case, our <strong>free</strong> report is a great place to start.</p>
<div class="lb-trans"><p>想知道分析师如何看待亨斯迈的未来与行业的对比吗？那么我们的 <strong>免费</strong> 报告是一个很好的起点。</p>
</div><h2>Do Revenue Forecasts Match The Low P/S Ratio?</h2>
<div class="lb-trans"><h2>收入预测是否与低市销率相符？</h2>
</div><p>The only time you'd be truly comfortable seeing a P/S as low as Huntsman's is when the company's growth is on track to lag the industry.</p>
<div class="lb-trans"><p>您唯一会真正感到舒适的情况是，当公司的增长预计将落后于行业时，市销率低至亨斯迈的水平。</p>
</div><p>Taking a look back first, the company's revenue growth last year wasn't something to get excited about as it posted a disappointing decline of 3.5%. This means it has also seen a slide in revenue over the longer-term as revenue is down 32% in total over the last three years. So unfortunately, we have to acknowledge that the company has not done a great job of growing revenue over that time.</p>
<div class="lb-trans"><p>首先回顾一下，去年公司的收入增长并不令人兴奋，出现了令人失望的 3.5% 的下降。这意味着在更长的时间内，收入也出现了下滑，过去三年总收入下降了 32%。因此，不幸的是，我们必须承认公司在这段时间内未能有效地增长收入。</p>
</div><p>Turning to the outlook, the next year should generate growth of 1.1% as estimated by the analysts watching the company. That's shaping up to be materially lower than the 5.5% growth forecast for the broader industry.</p>
<div class="lb-trans"><p>展望未来，分析师预计明年将实现 1.1% 的增长。这显然低于更广泛行业的 5.5% 的增长预测。</p>
</div><p>In light of this, it's understandable that Huntsman's P/S sits below the majority of other companies. It seems most investors are expecting to see limited future growth and are only willing to pay a reduced amount for the stock.</p>
<div class="lb-trans"><p>鉴于此，亨斯迈的市销率低于大多数其他公司是可以理解的。似乎大多数投资者预计未来增长有限，因此只愿意为该股票支付较低的价格。</p>
</div><h2>What Does Huntsman's P/S Mean For Investors?</h2>
<div class="lb-trans"><h2>亨斯迈的市销率对投资者意味着什么？</h2>
</div><p>The latest share price surge wasn't enough to lift Huntsman's P/S close to the industry median. While the price-to-sales ratio shouldn't be the defining factor in whether you buy a stock or not, it's quite a capable barometer of revenue expectations.</p>
<div class="lb-trans"><p>最新的股价飙升并不足以将亨斯迈的市销率拉近行业中位数。虽然市销率不应成为您是否购买股票的决定性因素，但它是收入预期的一个相当有效的晴雨表。</p>
</div><p>We've established that Huntsman maintains its low P/S on the weakness of its forecast growth being lower than the wider industry, as expected. Shareholders' pessimism on the revenue prospects for the company seems to be the main contributor to the depressed P/S. The company will need a change of fortune to justify the P/S rising higher in the future.</p>
<div class="lb-trans"><p>我们已经确定亨斯迈维持其低市销率的原因在于其预测增长低于更广泛行业的预期。股东对公司收入前景的悲观情绪似乎是导致市销率低迷的主要原因。公司需要改变运势，以证明未来市销率的上升是合理的。</p>
</div><p>We don't want to rain on the parade too much, but we did also find <strong>2 warning signs for Huntsman</strong> (1 doesn't sit too well with us!) that you need to be mindful of.</p>
<div class="lb-trans"><p>我们不想过于泼冷水，但我们确实发现了 <strong>亨斯迈的 2 个警告信号</strong>（其中 1 个让我们感到不安！）您需要注意。</p>
</div><p>Of course, <strong>profitable companies with a history of great earnings growth are generally safer bets</strong>. So you may wish to see this <strong>free</strong> collection of other companies that have reasonable P/E ratios and have grown earnings strongly.</p>
<div class="lb-trans"><p>当然，<strong>盈利能力强且有良好盈利增长历史的公司通常是更安全的投资</strong>。因此，您可能希望查看这份 <strong>免费</strong> 的其他公司集合，这些公司具有合理的市盈率并且盈利增长强劲。</p>
</div>

亨斯迈公司（NYSE:HUN）股票上涨 27% 是否合理，需要在此之前提高收入